Danaher (NYSE:DHR) Issues FY 2026 Earnings Guidance

Danaher (NYSE:DHR) updated its FY 2026 earnings guidance on Wednesday. The company provided EPS guidance of 8.350-8.500 for the period, compared to the consensus EPS estimate of 8.420. The company issued revenue guidance of -.

Danaher Trading Down 0.2%

Danaher stock opened at $236.18 on Wednesday. The company has a quick ratio of 1.10, a current ratio of 1.52 and a debt-to-equity ratio of 0.33. The firm has a 50-day moving average price of $230.80 and a two-hundred day moving average price of $213.70. The firm has a market capitalization of $166.82 billion, a price-to-earnings ratio of 48.70, a PEG ratio of 3.60 and a beta of 0.89. Danaher has a 52-week low of $171.00 and a 52-week high of $258.23.

Danaher Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 30th. Stockholders of record on Friday, December 26th will be issued a $0.32 dividend. The ex-dividend date is Friday, December 26th. This represents a $1.28 annualized dividend and a dividend yield of 0.5%. Danaher’s dividend payout ratio is 26.39%.

Analyst Upgrades and Downgrades

A number of research firms recently commented on DHR. Wells Fargo & Company increased their price objective on Danaher from $230.00 to $240.00 and gave the stock an “equal weight” rating in a report on Monday, December 15th. Guggenheim raised their target price on Danaher from $250.00 to $275.00 and gave the company a “buy” rating in a report on Friday, January 2nd. Leerink Partners boosted their price target on Danaher from $260.00 to $270.00 and gave the company an “outperform” rating in a research note on Friday, January 16th. JPMorgan Chase & Co. increased their price objective on shares of Danaher from $260.00 to $270.00 and gave the company an “overweight” rating in a research note on Wednesday, October 22nd. Finally, KeyCorp reissued an “overweight” rating on shares of Danaher in a report on Thursday, December 18th. Twenty equities research analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $252.09.

Insider Activity

In other news, SVP Brian W. Ellis sold 21,776 shares of Danaher stock in a transaction on Wednesday, November 12th. The stock was sold at an average price of $219.23, for a total value of $4,773,952.48. Following the transaction, the senior vice president owned 14,553 shares in the company, valued at approximately $3,190,454.19. This trade represents a 59.94% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Teri List sold 3,298 shares of the company’s stock in a transaction that occurred on Tuesday, November 18th. The stock was sold at an average price of $226.50, for a total transaction of $746,997.00. Following the transaction, the director owned 20,762 shares of the company’s stock, valued at approximately $4,702,593. This represents a 13.71% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 30,248 shares of company stock valued at $6,609,663 in the last quarter. Company insiders own 11.20% of the company’s stock.

Institutional Investors Weigh In On Danaher

Several hedge funds and other institutional investors have recently modified their holdings of the company. Integrated Investment Consultants LLC raised its holdings in shares of Danaher by 9.5% in the 3rd quarter. Integrated Investment Consultants LLC now owns 1,722 shares of the conglomerate’s stock worth $341,000 after acquiring an additional 149 shares during the last quarter. Aureus Asset Management LLC boosted its holdings in Danaher by 37.8% during the 3rd quarter. Aureus Asset Management LLC now owns 12,833 shares of the conglomerate’s stock worth $2,544,000 after acquiring an additional 3,520 shares during the last quarter. Palisade Asset Management LLC raised its holdings in shares of Danaher by 0.3% in the third quarter. Palisade Asset Management LLC now owns 20,450 shares of the conglomerate’s stock valued at $4,054,000 after purchasing an additional 69 shares during the last quarter. Morningstar Investment Management LLC bought a new position in shares of Danaher during the 3rd quarter worth approximately $11,874,000. Finally, Kestra Private Wealth Services LLC lifted its holdings in Danaher by 0.3% during the third quarter. Kestra Private Wealth Services LLC now owns 15,421 shares of the conglomerate’s stock worth $3,057,000 after acquiring an additional 48 shares during the period. Institutional investors own 79.05% of the company’s stock.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.